Facebook Billionaire Investing in a Shocking New Industry
Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.
And today, you could get in on the ground floor

PRAX Insider Trading (Praxis Precision Medicines)

Insider Ownership Percentage: 8.80%
Insider Buying (Last 12 Months): $100,303.68
Insider Selling (Last 12 Months): $0.00

Praxis Precision Medicines Insider Trading History Chart

Praxis Precision Medicines Share Price & Price History

$21.52
▼ -1.07 (-4.74%)
As of 06/18/2021 01:00 AM ET
Days: 30 | 90 | 365
Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1Interstate Cannabis

Praxis Precision Medicines Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2020Marcio SouzaCEOBuy3,846$26.08$100,303.6824,450View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Praxis Precision Medicines (NASDAQ:PRAX)

94.73% of Praxis Precision Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Praxis Precision Medicines Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2021Citadel Advisors LLC1,602,880$52.51M0.0%+0.5%4.146%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC25,689$0.84M0.0%N/A0.066%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.136,995$4.49M0.0%-45.2%0.354%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC474,456$15.54M0.2%-17.4%1.227%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley4,409$0.14M0.0%-69.2%0.011%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC1,602,880$52.51M0.0%+0.5%4.146%Search for SEC Filing on Google Icon
5/17/2021Royal Bank of Canada864$28K0.0%+204.2%0.002%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP251,663$8.24M0.2%-16.7%0.651%Search for SEC Filing on Google Icon
5/17/2021Janus Henderson Group PLC1,063,389$34.85M0.0%+18.5%2.750%Search for SEC Filing on Google Icon
5/17/2021Acuta Capital Partners LLC154,229$5.05M1.8%+103.9%0.399%Search for SEC Filing on Google Icon
5/17/2021Nuveen Asset Management LLC56,565$1.85M0.0%+39.3%0.146%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.99,669$3.27M0.0%+51.6%0.258%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp33,248$1.09M0.0%+12.1%0.086%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.46,687$1.53M0.0%+2,032.8%0.121%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp120,690$3.95M0.0%-5.2%0.312%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC210,158$6.88M0.0%+2.5%0.544%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.7,456$0.24M0.0%+33.6%0.019%Search for SEC Filing on Google Icon
5/12/2021E Fund Management Co. Ltd.1,564$51K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund10,500$0.34M0.0%+22.1%0.027%Search for SEC Filing on Google Icon
5/11/2021Jennison Associates LLC197,510$6.47M0.0%-0.8%0.511%Search for SEC Filing on Google Icon
5/10/2021Rafferty Asset Management LLC37,594$1.23M0.0%N/A0.097%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,208,051$39.58M0.0%+0.9%3.127%Search for SEC Filing on Google Icon
5/7/2021Harvard Management Co. Inc.778,517$25.50M1.4%-1.8%2.015%Search for SEC Filing on Google Icon
5/6/2021Rhumbline Advisers10,589$0.35M0.0%+5.0%0.027%Search for SEC Filing on Google Icon
5/6/2021Alliancebernstein L.P.891,553$29.21M0.0%+28.1%2.308%Search for SEC Filing on Google Icon
5/5/2021Los Angeles Capital Management LLC18,430$0.60M0.0%N/A0.048%Search for SEC Filing on Google Icon
4/15/2021First Midwest Bank Trust Division6,930$0.23M0.0%N/A0.018%Search for SEC Filing on Google Icon
4/5/2021Pacer Advisors Inc.870$29K0.0%N/A0.002%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.75,000$4.13M0.1%N/A0.196%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.5,580$0.31M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC574,456$31.61M0.3%N/A1.501%Search for SEC Filing on Google Icon
2/16/2021Orbimed Advisors LLC255,600$14.06M0.1%N/A0.668%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.75,000$4.13M0.1%N/A0.196%Search for SEC Filing on Google Icon
2/16/2021Nuveen Asset Management LLC40,614$2.23M0.0%N/A0.106%Search for SEC Filing on Google Icon
2/16/2021Davidson Kempner Capital Management LP10,000$0.55M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/16/2021Avoro Capital Advisors LLC1,545,495$68.71M1.2%N/A4.039%Search for SEC Filing on Google Icon
2/16/2021Janus Henderson Group PLC897,372$49.37M0.0%N/A2.345%Search for SEC Filing on Google Icon
2/16/2021Acuta Capital Partners LLC75,645$4.16M1.1%N/A0.198%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.69,760$3.84M0.0%N/A0.182%Search for SEC Filing on Google Icon
2/13/2021American International Group Inc.6,411$0.35M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/13/2021Vida Ventures Advisors LLC2,939,329$161.72M33.2%N/A7.682%Search for SEC Filing on Google Icon
2/12/2021Opaleye Management Inc.63,416$3.49M0.5%N/A0.166%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP5,000$0.28M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/12/2021Laurion Capital Management LP50,000$2.75M0.0%N/A0.131%Search for SEC Filing on Google Icon
2/12/2021The Manufacturers Life Insurance Company6,362$0.35M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/12/2021Harvard Management Co. Inc.792,617$43.61M2.4%N/A2.072%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC5,000$0.28M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp127,325$7.01M0.0%N/A0.333%Search for SEC Filing on Google Icon
2/11/2021Citigroup Inc.2,189$0.12M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/11/2021Artal Group S.A.750,000$41.27M0.9%N/A1.960%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers10,085$0.56M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN5,723$0.32M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp29,668$1.63M0.0%N/A0.078%Search for SEC Filing on Google Icon
2/8/2021Alliancebernstein L.P.696,252$38.31M0.0%N/A1.820%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund8,600$0.47M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/6/2021Jennison Associates LLC199,175$10.96M0.0%N/A0.521%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.1,197,396$65.88M0.0%N/A3.129%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Praxis Precision Medicines logo
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Cambridge, Massachusetts.
Read More on Praxis Precision Medicines

Today's Range

Now: $21.52
$21.05
$23.14

50 Day Range

MA: $23.73
$18.43
$32.22

52 Week Range

Now: $21.52
$17.68
$60.95

Volume

1,614,100 shs

Average Volume

288,430 shs

Market Capitalization

$832.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Praxis Precision Medicines?

Praxis Precision Medicines' top insider investors include:
  1. Marcio Souza (CEO)

Who are the major institutional investors of Praxis Precision Medicines?

Praxis Precision Medicines' top institutional investors include:
  1. Citadel Advisors LLC — 4.15%
  2. Citadel Advisors LLC — 4.15%
  3. BlackRock Inc. — 3.13%
  4. Janus Henderson Group PLC — 2.75%
  5. Alliancebernstein L.P. — 2.31%
  6. Harvard Management Co. Inc. — 2.02%

Which major investors are selling Praxis Precision Medicines stock?

In the last quarter, PRAX stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. Verition Fund Management LLC
  3. Woodline Partners LP
  4. Harvard Management Co. Inc.
  5. Morgan Stanley
  6. Northern Trust Corp
  7. Jennison Associates LLC

Which major investors are buying Praxis Precision Medicines stock?

Within the previous quarter, PRAX stock was bought by institutional investors including:
  1. Alliancebernstein L.P.
  2. Janus Henderson Group PLC
  3. Acuta Capital Partners LLC
  4. Citigroup Inc.
  5. Rafferty Asset Management LLC
  6. Goldman Sachs Group Inc.
  7. Millennium Management LLC
  8. Los Angeles Capital Management LLC
Facebook Billionaire Investing in a Shocking New Industry
Peter Thiel, the billionaire investor behind Facebook, PayPal, and eBay, has a new darling industry in his sights. And he's betting a massive $210 million on its success. That's not pocket change.
And today, you could get in on the ground floor